Medline Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	56,331	34,953	-	-	-
Enterprise Value	67,369	50,606	-	-	-
Last Close Price	42.88	42.00	-	-	-
PE Ratio	29.97	30.16	-	-	-
PS Ratio	1.98	1.23	-	-	-
PB Ratio	3.24	1.81	-	-	-
P/FCF Ratio	44.57	27.65	-	-	-
P/OCF Ratio	32.30	20.04	-	-	-
EV/Sales Ratio	2.37	1.78	-	-	-
EV/EBITDA Ratio	21.12	15.86	-	-	-
EV/EBIT Ratio	30.92	23.22	-	-	-
EV/FCF Ratio	53.30	40.04	-	-	-
Debt / Equity Ratio	0.68	0.68	1.05	1.00	-
Debt / EBITDA Ratio	3.92	3.92	5.23	6.89	-
Debt / FCF Ratio	10.30	10.30	12.03	12.02	-
Net Debt / Equity Ratio	0.57	0.57	1.03	0.90	-
Net Debt / EBITDA Ratio	3.46	3.46	5.32	6.41	-
Net Debt / FCF Ratio	8.73	8.73	11.83	10.82	-
Asset Turnover	0.76	0.76	0.71	-	-
Inventory Turnover	4.53	4.53	4.48	-	-
Quick Ratio	2.21	2.21	1.43	2.18	-
Current Ratio	4.29	4.29	3.39	4.13	-
Return on Equity (ROE)	6.53%	6.53%	7.29%	-	-
Return on Assets (ROA)	3.66%	3.66%	3.72%	-	-
Return on Invested Capital (ROIC)	6.44%	6.40%	6.40%	3.92%	-
Return on Capital Employed (ROCE)	6.10%	6.10%	6.40%	4.20%	-
Earnings Yield	2.06%	3.32%	-	-	-
FCF Yield	2.24%	3.62%	-	-	-
Payout Ratio	-	44.69%	126.50%	48.72%	-
Buyback Yield / Dilution	95.36%	95.36%	0.19%	-	-

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q